deCODE genetics (Nasdaq: DCGN - News) today announced
that its presentation at the Jefferies Life Science Conference on Wednesday,
June 28, 2006, will be webcast live. The presentation will be delivered at
3:30pm Eastern Time/7:30 pm GMT at the Mandarin Oriental Hotel in New York.
The webcast can be accessed through the Investors page on deCODE's website,
http://www.decode.com. Those interested in listening should log on a few
minutes in advance in order to download any software or complete any sign-
in that may be required.
About deCODE
deCODE genetics (NASDAQ:DCGN) is a global leader in applying human genetics
to develop drugs for common diseases. Our population approach has enabled
us to discover and target key biological pathways involved in conditions
ranging from heart attack to cancer. We are turning these discoveries into
new medicine to better treat and prevent many of the biggest challenges
to public health. deCODE is delivering on the promise of the new genetics.SM
Visit us on the web at www.decode.com.
Any statements contained in this presentation that relate to future plans,
events or performance are forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to a number of risks and uncertainties that could
cause actual results to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, among others, those
relating to technology and product development, integration of acquired
businesses, market acceptance, government regulation and regulatory approval
processes, intellectual property rights and litigation, dependence on collaborative
relationships, ability to obtain financing, competitive products, industry
trends and other risks identified in deCODE’s filings with the Securities
and Exchange Commission. deCODE undertakes no obligation to update or alter
these forward-looking statements as a result of new information, future
events or otherwise.
